In Table 2 of the article cited above, there is an error in the calculation of the percent of subjects meeting a study end point. The placebo value for “Hospitalization for congestive heart failure” is 6 (0.4) in the original table presentation. The correct value is 6 (0.6).
The section of the corrected table is presented below.
| Composite CVD End Point by Each Component‡ . | . | . |
|---|---|---|
| Myocardial infarction | 7 (0.3) | 9 (0.9) |
| Stroke | 5 (0.2) | 6 (0.6) |
| Hospitalization for unstable angina | 9 (0.4) | 9 (0.9) |
| Hospitalization for congestive heart failure | 9 (0.4) | 6 (0.6) |
| Coronary revascularization | 11 (0.5) | 8 (0.8) |
| Composite CVD End Point by Each Component‡ . | . | . |
|---|---|---|
| Myocardial infarction | 7 (0.3) | 9 (0.9) |
| Stroke | 5 (0.2) | 6 (0.6) |
| Hospitalization for unstable angina | 9 (0.4) | 9 (0.9) |
| Hospitalization for congestive heart failure | 9 (0.4) | 6 (0.6) |
| Coronary revascularization | 11 (0.5) | 8 (0.8) |
© 2016 by the American Diabetes Association.
2016
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
